$23.18-0.11 (-0.47%)
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
Tactile Systems Technology, Inc. in the Healthcare sector is trading at $23.29. Wall Street consensus targets $39.50 (4 analysts), implying a +69.6% move over the next 12 months. The stock is currently 38% below its 52-week high of $37.77, remaining 4.2% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 95/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of ly...
Tactile Systems Technology, Inc.'s ( NASDAQ:TCMD ) strong earnings report was rewarded with a positive stock price...
Tactile Systems Technology, Inc. ( NASDAQ:TCMD ) defied analyst predictions to release its first-quarter results, which...
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Moby summary of Tactile Systems Technology, Inc.'s Q1 2026 earnings call
Tactile Systems Technology (NASDAQ:TCMD) reported first-quarter 2026 revenue of $75.3 million, up 23% year-over-year, as management pointed to “focused execution” on strategic priorities, continued commercial momentum, and operational changes made ahead of Medicare’s new prior authorization requirem